Abstract
Objective: Epistaxis is a relatively remarkable clinical symptom in dogs that should be included in the differential diagnoses of diseases. Material and Methods: The present author's interest in this subject arose following receipt of several cases within the last 10 years. The purpose of the present article was to evaluate 34 dogs with epistaxis retrospectively. Results: There was bilateral (n=13) or unilateral (n=21) epistaxis, in which chronicity was evident in 13 dogs. Etiology deemed infectious (n=28), non-infectious (n=5) and unknown origin (n=1) causes. The infectious causes involved 13 cases with canine visceral leishmaniasis and other 9 with canine monocytic ehrlichiosis, followed by 6 co-infected dogs. Activated partial thromboplastin time was significantly (p<0.001) prolonged in coinfected groups. Regarding mean prothrombin time, a statistically important prolongation (p<0.001) was evident among leishmaniasis within other groups. Mean FIB values deemed elevated among all infected groups in contrast to healthy ones (p<0.001). Mean platelet values were decreased in E. canis mono and co-infected groups (p<0.001). Non-infectious diseases consisted of firearm injury (n=2), nasal malignant melanoma (n=1), lymphoma (n=1) and autoimmune hemolytic anemia (n=1). Conclusion: Taking into account review of this case series, it might be suggested that epistaxis should be on the list of clinical signs for infectious and non-infectious causes, which should be promptly treated based on probable tests and relevant findings.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.